; (2) emphasize bringing new test strip technology intended for testing human specimens in clinical settings to support on-site clinical decision-making; and (3) include guidance on available authorization pathways for test strips described in paragraphs (1) and (2). 5. Study on fentanyl test strip interventions The Secretary of Health and Human Services shall— (1) conduct a study on the impact of the availability, accessibility, and usage of drug checking supplies, including test strips, on frequency of overdose, overdose deaths, and engagement in substance use disorder treatment; and (2) not later than 2 years after the date of enactment of this Act, submit to Congress a report on the study conducted under paragraph (1). 6. Definition In this Act, the term test strip means a rapid response, single use diagnostic that can be used to detect the adulteration of a drug with, or the presence in a human specimen of, any substance that may lead to increased morbidity or mortality, such as fentanyl, xylazine, or another synthetic opioid or emerging substance.